Context Therapeutics Inc.

NASDAQ:CNTX

Biotechnology

Healthcare
$0.69 +2.93%

+$0.02 today

Market cap
$63.67M
Beta
1.61
P/E (TTM)
-1.5
EPS (TTM)
-$0.42
52W Low $0.56High $3.62

Volume 1.71M

Average 1.16M

CNTX Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How CNTX compares with its peers on the latest reported figures

CNTX Competitors Peer median
Operating Margin for CNTX and competitors
Company Period LTM level YoY 3-year change
MGNXMacroGenics, Inc.LTM Mar 2026-40.5% +24.7 pp+32.2 pp
OVIDOvid Therapeutics Inc.LTM Mar 2026-670.2% +9733.9 pp+3111.2 pp
ORMPOramed Pharmaceuticals Inc.FY2025-754.4% —+747.6 pp
WHWKWhitehawk Therapeutics IncFY2025-1601.1% -1341.5 pp-1189.2 pp
STTKShattuck Labs, Inc.LTM Mar 2026-5266.4% -3640.0 pp+10697.2 pp
IMAImageneBio IncFY2025-6056.4% -4999.2 pp-5602.4 pp
CLNNClene Inc.LTM Mar 2026-15535.1% -7553.1 pp-1307.0 pp
CNTBConnect Biopharma Holdings LimitedFY2025-90740.6% -90654.4 pp—
IFRXInflaRx N.V.LTM Mar 2026-144445.0% -103193.3 pp—
CNTXContext Therapeutics Inc.FY2025— ——
KLRSKalaris Therapeutics IncFY2025— ——
Peer median (excluding CNTX) -5266.4%-4319.6 pp+32.2 pp

Competitors are the stored peer set for CNTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development3.81M7.09M17.78M22.7M31.86M
Selling, General & Admin3.63M7.79M7.29M7.22M7.85M
Operating Expenses10.53M15.38M25.07M29.92M39.7M
Depreciation & Amortization09.27K12.04K10.88K16.25K
EBITDA(7.44M)(14.87M)(23.95M)(26.71M)(36.11M)
EBITDA Margin—————
Operating Income(10.53M)(15.38M)(25.07M)(29.92M)(39.7M)
Operating Margin—————
Interest Income64547.27K1.16M3.2M3.38M
Interest Expense64.24K547.27K000
Other Income / Expenses68.95K545.26K1.11M3.2M3.58M
Income Before Tax(10.46M)(14.84M)(23.96M)(26.73M)(36.12M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(10.46M)(14.84M)(23.96M)(26.73M)(36.12M)
Net Margin—————
EPS (Basic)(3.69)(0.93)(1.50)(0.46)(0.38)
EPS (Diluted)(3.69)(0.93)(1.50)(0.46)(0.38)
Weighted Avg Shares2.83M15.97M15.97M58.42M95.19M
Weighted Avg Shares (Diluted)2.83M15.97M15.97M58.42M95.19M

Context Therapeutics Inc.

NASDAQ:CNTX

Intrinsic Alpha fair value

Locked

Current Price

$0.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.